Shengan Chen

12 Middle Urumqi Road
Shanghai, 200040, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Geographic and Demographic Trends in Allergen Sensitization: Evidence From a Nationwide Chinese Cohort.

Geographic and Demographic Trends in Allergen Sensitization: Evidence From a Nationwide Chinese Cohort.

Journal: Allergy

Published: November 11, 2025

Breaking the barrier: Transforming the diagnosis and management of penicillin and cephalosporin allergy in China.

Breaking the barrier: Transforming the diagnosis and management of penicillin and cephalosporin allergy in China.

Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases

Published: August 13, 2025

Mandatory Preemptive Skin Testing and Its Impact on Penicillin Allergy Labeling Across Different Healthcare Settings in Mainland China and Hong Kong.

Mandatory Preemptive Skin Testing and Its Impact on Penicillin Allergy Labeling Across Different Healthcare Settings in Mainland China and Hong Kong.

Journal: Allergy

Published: July 18, 2025

Expanding the Genetic and Clinical Spectrum of Hereditary Angioedema with Normal C1 Inhibitor: Novel Variants and Treatment Insights.

Expanding the Genetic and Clinical Spectrum of Hereditary Angioedema with Normal C1 Inhibitor: Novel Variants and Treatment Insights.

Journal: Journal of clinical immunology

Published: February 15, 2025

A questionnaire-based cross-sectional survey of cutaneous adverse events in cancer patients treated with molecular targeted therapy and immunotherapies.

A questionnaire-based cross-sectional survey of cutaneous adverse events in cancer patients treated with molecular targeted therapy and immunotherapies.

Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer

Published: August 24, 2024

Unveiling the impact of traditional Chinese herbal medicines on cutaneous adverse drug reactions: A landmark 15-year nationwide study.

Unveiling the impact of traditional Chinese herbal medicines on cutaneous adverse drug reactions: A landmark 15-year nationwide study.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology

Published: July 24, 2024

Pulmonary interstitial lesions in pemphigus mouse model: Verifying pemphigus may not be only limited to skin and mucosa.

Pulmonary interstitial lesions in pemphigus mouse model: Verifying pemphigus may not be only limited to skin and mucosa.

Journal: Experimental dermatology

Published: February 07, 2024

Epidemiological Insights into Autoimmune Bullous Diseases in China: A Comprehensive Analysis.

Epidemiological Insights into Autoimmune Bullous Diseases in China: A Comprehensive Analysis.

Journal: Journal of epidemiology and global health

Published: January 02, 2024

Efficacy and Safety of Hydrogen Therapy in Patients with Early-Stage Interstitial Lung Disease: A Single-Center, Randomized, Parallel-Group Controlled Trial.

Efficacy and Safety of Hydrogen Therapy in Patients with Early-Stage Interstitial Lung Disease: A Single-Center, Randomized, Parallel-Group Controlled Trial.

Journal: Therapeutics and clinical risk management

Published: September 01, 2023

Dupilumab combined with low-dose systemic steroid therapy improves efficacy and safety for bullous pemphigoid.

Dupilumab combined with low-dose systemic steroid therapy improves efficacy and safety for bullous pemphigoid.

Journal: Dermatologic therapy

Published: April 12, 2022

Comprehensive assessment of T cell receptor β repertoire in Stevens-Johnson syndrome/toxic epidermal necrolysis patients using high-throughput sequencing.

Comprehensive assessment of T cell receptor β repertoire in Stevens-Johnson syndrome/toxic epidermal necrolysis patients using high-throughput sequencing.

Journal: Molecular immunology

Published: September 22, 2018

HLA-C*12:02 is strongly associated with Xuesaitong-induced cutaneous adverse drug reactions.

HLA-C*12:02 is strongly associated with Xuesaitong-induced cutaneous adverse drug reactions.

Journal: The pharmacogenomics journal

Published: January 19, 2018

Showing 1-12 of 14

Last Updated: 09/26/2026